Text Size

Availability of Poor Quality Embryos

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Yang Jie, The Second Affiliated Hospital of Kunming Medical University
ClinicalTrials.gov Identifier:
NCT01715545
First received: October 24, 2012
Last updated: October 25, 2012
Last verified: October 2012
History of Changes
  Purpose

The purpose of this study is to explore a method to identify the viability of day-3 poor quality embryos


Condition
Infertility

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Availability of Poor Quality Embryos in Frozen-thawed Embryo Transfer Cycles

Resource links provided by NLM:

MedlinePlus related topics: Infertility
U.S. FDA Resources

Further study details as provided by The Second Affiliated Hospital of Kunming Medical University:

Primary Outcome Measures:
  • pregnancy rate [ Time Frame: 5 weeks ] [ Designated as safety issue: Yes ]

Enrollment: 481
Study Start Date: January 2011
Study Completion Date: October 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
day-3 poor quality embryos
developmental stage
day3 poor quality embryos day4 morular day-5/6 blastocyst

Detailed Description:

Day-3 poor quality embryos are related to significant lower clinical pregnancy,so freezing numerous poor quality embryos are clinical impractical. To ensure the successful pregnancy and to enhance the availability of the poor quality embryos, day-3 poor quality embryos are further cultured to different developmental stage and then cryopreserved. The viability of these embryos are tested in frozen-thawed transfer.

  Eligibility

Ages Eligible for Study:   20 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

unfertile women

Criteria

Inclusion Criteria:

  • unfertile women

Exclusion Criteria:

  • women older than 40 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01715545

Locations
China, Yunnan
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China, 650101
Sponsors and Collaborators
The Second Affiliated Hospital of Kunming Medical University
Investigators
Principal Investigator: Jie Yang The Second Affiliated Hospital of Kunming Medical University
  More Information

No publications provided

Responsible Party: Yang Jie, The Second Affiliated Hospital of Kunming Medical University
ClinicalTrials.gov Identifier: NCT01715545     History of Changes
Other Study ID Numbers: 200601YJ
Study First Received: October 24, 2012
Last Updated: October 25, 2012
Health Authority: China: Ministry of Health

Keywords provided by The Second Affiliated Hospital of Kunming Medical University:
day-3 poor quality embryo
vitrification
clinical outcome

Additional relevant MeSH terms:
Infertility
Genital Diseases, Male
Genital Diseases, Female

ClinicalTrials.gov processed this record on May 19, 2013